Crafted by The Atlantic’s marketing team and paid for by Amgen
Share
Re:think Original / Amgen
Cautiously Close: Inside the Race Against Cancer
Share

CAUTIOUSLY CLOSEINSIDE THE RACE AGAINST CANCER

Science may be closer than ever to beating cancer, and may have the tools already. The once-impossible dream of out-living the disease may soon be within reach — not for the next generation or in the distant future, but for people suffering today. Scientists once said that cancer would never be defeated — the disease was too complex, too subtle. With innovations like immunotherapies and precision-designed molecules, the biotech industry has learned ways to combat cancer’s life-altering power. Yet the most revolutionary breakthrough on the horizon may be the ability to bring these solutions to market in ways uniquely customized to the needs of individual patients. It isn’t just technology beating cancer, but a community of researchers, doctors, technicians, and above all patients themselves marshaling powers already within us.

USA-OCF-80840
© 2019 Amgen Inc. All rights reserved

Closing In on the Elusive

Inside The Race Against Cancer

read the article now